We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+13.82%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.5B
AUM Growth
+$378M
Cap. Flow
+$252M
Cap. Flow %
1.74%
Top 10 Hldgs %
26.25%
Holding
735
New
61
Increased
261
Reduced
285
Closed
31

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$73.6M
2
GILD icon
Gilead Sciences
GILD
+$57M
3
MSFT icon
Microsoft
MSFT
+$44.1M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$38.6M
5
NU icon
Nu Holdings
NU
+$38M

Top Sells

Rank Stock Value
1
SGEN
Seagen Inc. Common Stock
SGEN
+$112M
2
RY icon
Royal Bank of Canada
RY
+$44.3M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$40.1M
4
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$38.9M
5
MRK icon
Merck
MRK
+$31.7M

Sector Composition

Rank Sector Weight
1 Technology 30.32%
2 Healthcare 28.88%
3 Consumer Discretionary 8.63%
4 Financials 8.52%
5 Industrials 6.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SYF icon
201
Synchrony
SYF
$24.9B
$15M 0.1%
392,146
-248,764
-39% -$7.87M
SNOW icon
202
Snowflake
SNOW
$94.9B
$15M 0.1%
75,179
+49,361
+191% +$8.35M
PWR icon
203
Quanta Services
PWR
$87.6B
$14.9M 0.1%
69,058
+58,254
+539% +$10.8M
HAL icon
204
Halliburton
HAL
$26.3B
$14.8M 0.1%
410,428
+341,261
+493% +$13.1M
DFS
205
DELISTED
Discover Financial Services
DFS
$14.8M 0.1%
131,775
-7,553
-5% -$698K
CAH icon
206
Cardinal Health
CAH
$54.3B
$14.6M 0.1%
145,045
+8,001
+6% +$794K
BRKR icon
207
Bruker
BRKR
$9.4B
$14.5M 0.1%
197,978
+58,792
+42% +$3.77M
LEGN icon
208
Legend Biotech
LEGN
$3.69B
$14.5M 0.1%
241,032
+10,000
+4% +$634K
DOV icon
209
Dover
DOV
$27.2B
$14.5M 0.1%
94,253
+1,200
+1% +$168K
CLH icon
210
Clean Harbors
CLH
$15.9B
$14.5M 0.1%
82,807
+26,724
+48% +$4.39M
MNSO icon
211
MINISO
MNSO
$3.75B
$14.3M 0.1%
701,573
-742,577
-51% -$17.8M
WMT icon
212
Walmart Inc
WMT
$902B
$14.2M 0.1%
270,366
+24,855
+10% +$1.32M
DGX icon
213
Quest Diagnostics
DGX
$26.1B
$14.2M 0.1%
102,847
-16,875
-14% -$2.22M
IDYA icon
214
IDEAYA Biosciences
IDYA
$3.45B
$14.1M 0.1%
395,019
-35,000
-8% -$1.04M
IOVA icon
215
Iovance Biotherapeutics
IOVA
$2.11B
$14M 0.1%
1,727,822
-1,020,031
-37% -$5.34M
GIS icon
216
General Mills
GIS
$20.1B
$13.7M 0.09%
210,911
-84,740
-29% -$5.47M
ZTO icon
217
ZTO Express
ZTO
$18.2B
$13.6M 0.09%
637,100
-838,010
-57% -$19M
FWONK icon
218
Liberty Media Series C
FWONK
$25.3B
$13.4M 0.09%
+212,693
New +$13.9M
PNC icon
219
PNC Financial Services
PNC
$100B
$13.3M 0.09%
86,156
-50,709
-37% -$6.57M
GE icon
220
GE Aerospace
GE
$375B
$13.3M 0.09%
130,189
+4,937
+4% +$457K
DELL icon
221
Dell
DELL
$247B
$13M 0.09%
169,752
+49,940
+42% +$3.53M
VLTO icon
222
Veralto
VLTO
$24B
$12.7M 0.09%
+154,182
New +$11.5M
GH icon
223
Guardant Health
GH
$19.1B
$12.6M 0.09%
466,137
-25,000
-5% -$656K
CLDX icon
224
Celldex Therapeutics
CLDX
$2.79B
$12.6M 0.09%
317,509
-5,000
-2% -$147K
ASND icon
225
Ascendis Pharma A/S
ASND
$16.3B
$12.5M 0.09%
99,375
-40,000
-29% -$3.99M
7 8
9
10 11

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2023 Portfolio in Review

As of Q4 2023, Candriam SCA held 735 positions worth $14.5B, up 2.7% from $14.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Candriam SCA's Q4 2023 filing shows 61 new, 261 increased, 285 reduced and 31 closed positions. Its largest new stake was Nu Holdings: 4,696,438 shares worth $39.1M. The largest sale was Seagen Inc. Common Stock, an estimated $112M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Candriam SCA's largest Q4 2023 buy was Nu Holdings: 4,696,438 shares worth $39.1M.
  • Candriam SCA added most to Visa in Q4 2023, an estimated $73.6M increase.
  • Candriam SCA's biggest Q4 2023 reduction was Royal Bank of Canada, cutting an estimated $44.3M.
  • Candriam SCA fully exited Seagen Inc. Common Stock in Q4 2023, selling an estimated $112M.
  • Candriam SCA's ten largest holdings make up 26% of its $14.5B portfolio in Q4 2023.
  • Candriam SCA opened 61 new positions and closed 31 in Q4 2023.
  • Candriam SCA's portfolio value rose 2.7% quarter-over-quarter to $14.5B.

Based on Candriam SCA's 13F filing for Q4 2023, filed 14 Feb 2024.